The EMIF-AD PreclinAD study: study design and baseline cohort overview

BACKGROUND: Amyloid pathology is the pathological hallmark in Alzheimer’s disease (AD) and can precede clinical dementia by decades. So far it remains unclear how amyloid pathology leads to cognitive impairment and dementia. To design AD prevention trials it is key to include cognitively normal subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Konijnenberg, Elles, Carter, Stephen F., ten Kate, Mara, den Braber, Anouk, Tomassen, Jori, Amadi, Chinenye, Wesselman, Linda, Nguyen, Hoang-Ton, van de Kreeke, Jacoba A., Yaqub, Maqsood, Demuru, Matteo, Mulder, Sandra D., Hillebrand, Arjan, Bouwman, Femke H., Teunissen, Charlotte E., Serné, Erik H., Moll, Annette C., Verbraak, Frank D., Hinz, Rainer, Pendleton, Neil, Lammertsma, Adriaan A., van Berckel, Bart N. M., Barkhof, Frederik, Boomsma, Dorret I., Scheltens, Philip, Herholz, Karl, Visser, Pieter Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091034/
https://www.ncbi.nlm.nih.gov/pubmed/30075734
http://dx.doi.org/10.1186/s13195-018-0406-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091034/
https://www.ncbi.nlm.nih.gov/pubmed/30075734
http://dx.doi.org/10.1186/s13195-018-0406-7

Ejemplares similares